一、2018-2022年年报商誉有关情况存在虚假记载 （一）2018年未按规定执行商誉减值测试，导致2018年年报少计提商誉减值准备6，236.30万元。 一、鹏都农牧未依法及时披露控股股东非经营性资金占用。 二、鹏都农牧2020年年度报告、2021年半年度报告、2021年年度报告、2022年半年度报告、2022年年度 报告存在重大遗漏 许峰律师认为，在2021年4月29日到2024年8月15日之间买入鹏都农牧股票，并且在2024年8月15日后卖 出或继续持有股票的投资者，目前还可发起索赔。（鹏都农牧维权入口） 除了鹏都农牧投资者索赔案获得法院立案，2025年11月10日，许峰律师代理的世纪华通（维权） （002602）投资者索赔案再次向绍兴市中级人民法院立案，律师团队同步也还在持续接受其他投资者的 索赔委托。值得注意的是，许峰律师代理的部分世纪华通投资者索赔案已获赔到位。 2024年11月6日，世纪华通公告收到证监会《行政处罚决定书》，经查明，世纪华通违法事实如下： 2025年11月12日，上海久诚律师事务所许峰律师代理的鹏都农牧（002505）投资者索赔案获得长沙中院 立案，律师团队还在继续推进后续案件的 ...

上海久诚律师事务所许峰律师提示，元成股份（603388）虚假陈述引发的投资者索赔案目前又出现证据 方面的进展。（许峰律师专栏） 2025年10月9日，元成股份公告收到证监会浙江监管局下发的《行政处罚事先告知书》，许峰律师提 示，至此，元成股份所涉嫌的违法事实已基本清晰，如果投资者因此受损，目前已可发起索赔。 许峰律师代理的元成股份投资者索赔案已向法院提交立案，目前律师团队还在继续推进后续案件的立案 工作，还在继续接受其他投资者的索赔委托。 上述《行政处罚事先告知书》公告信息显示，经查明，元成股份、祝昌人涉嫌违法的事实如下： 2、元成股份2022年非公开发行股票文件编造重大虚假内容 上海久诚律师事务所主任许峰律师认为，综合相关违法事实，在2021年4月15日到2024年1月31日之间买 入元成股份股票，并在2024年1月31日之后卖出或继续持有股票的投资者，目前已可发起索赔。（元成 股份维权入口） 除了元成股份收到处罚事先告知书，2025年10月下旬，许峰律师代理的保利联合（维权）（002037）投 资者索赔案获赔到位。律师团队也还在继续接受其他投资者的索赔委托。目前该案已经进入诉讼时效倒 计时。 2024年1 ...

根据《民法典》、《证券法》及最高人民法院的关于虚假陈述民事赔偿司法解释的规定，上市公司、控 股股东、实际控制人、董监高人员及其中介机构等因虚假陈述等的证券欺诈行为导致证券投资者权益受 损的，应承担民事赔偿责任，赔偿范围包括：投资差额、佣金、印花税等。权益受损的证券投资者可以 向有管辖权的法院提起民事赔偿诉讼。 登录新浪财经APP 搜索【信披】查看更多考评等级 2025年11月7日，长江医药控股股份有限公司（简称：长药控股、*ST长药（维权），代码：300391） 发布《关于公司收到中国证券监督管理委员会立案告知书暨风险提示的公告》，称因公司涉嫌定期报告 等财务数据虚假记载，根据《中华人民共和国证券法》的有关规定，中国证券监督管理委员会决定对公 司立案调查。 2．以行政处罚决定为特征的前置条件取消后，投资者虽然可以直接诉讼，但由于调查手段有限，以立 案调查通知或行政监管措施决定作为直接诉讼的依据起诉存在败诉的风险，所以，我作为专业律师提示 投资者：行政处罚决定仍然应当作为提起诉讼的必要前提之一。 3．在拟提起的民事侵权诉讼案件中，上市公司退市与否，都不影响民事索赔侵权诉讼的进程，但有可 能会影响诉讼的进度。而进 ...

Core Points - Qingdao Zhongcheng (300208) has received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) for false statements in its financial reports [1][2] - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, is currently accepting claims from investors who suffered losses due to these violations [1][2] Summary by Sections Financial Misstatements - Qingdao Zhongcheng's annual reports from 2017 to 2022 contained significant false records, including: - 2017: Overstated revenue by 1,403.22 million, 92.18% of reported revenue; overstated profit by 552.77 million, 136.17% of reported profit [1] - 2018: Overstated revenue by 467.89 million, 36.00% of reported revenue; overstated profit by 217.76 million, 94.92% of reported profit [1] - 2019: Understated revenue by 672.44 million, 88.83% of reported revenue; understated profit by 285.38 million, 78.36% of reported profit [1] - 2020: Overstated intangible assets by 300.23 million, 6.53% of total assets; understated revenue by 343.08 million, 118.51% of reported revenue; understated profit by 281.80 million, 56.22% of reported profit [1] - 2021: Overstated intangible assets by 309.70 million, 7.37% of total assets; understated revenue by 0.73 million, 0.46% of reported revenue; overstated profit by 0.50 million, 5.83% of reported profit [1] - 2022: Overstated intangible assets by 309.70 million, 7.42% of total assets [1] Legal Proceedings - Investors who purchased Qingdao Zhongcheng stock between April 25, 2018, and April 29, 2024, may initiate claims for compensation [2] - The law firm is also handling claims for investors of Haofeng Technology (300419), which has also faced penalties from the CSRC for similar violations [2][3] Haofeng Technology Violations - Haofeng Technology was found to have inflated its 2020 revenue by 73.13 million, 11.43% of its annual revenue, due to misreporting related to financing activities [2][3] - Investors who bought Haofeng Technology stock between April 26, 2021, and December 27, 2023, are eligible to file claims [3]

Core Viewpoint - The case of Poly United (002037) has reached a settlement stage, with ongoing efforts to accept claims from other investors due to previous financial misconduct [1] Summary by Relevant Sections Legal Proceedings - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, is currently handling claims for investors against Poly United, with the case now in the settlement process [1] - The law firm continues to accept claims from other investors, indicating a broader scope of potential legal action [1] Financial Misconduct - The China Securities Regulatory Commission (CSRC) issued an administrative penalty against Poly United, revealing significant underreporting of bad debt provisions: - In 2019, the company underreported bad debt provisions by 43,121,976.07 yuan, resulting in an inflated net profit of 36,653,679.66 yuan, which was 19.95% of the disclosed amount [1] - In 2020, the underreported amount was 77,752,927.99 yuan, inflating net profit by 65,892,497.89 yuan, accounting for 43.24% of the disclosed amount [1] - In 2021, the company underreported bad debt provisions by 235,768,852.67 yuan, leading to an inflated net profit of 200,267,416.27 yuan, which was 124.47% of the disclosed amount, affecting the overall profit and loss for that year [1] Investor Claims - Investors who purchased Poly United shares between April 28, 2020, and April 28, 2023, and sold or held the shares after April 28, 2023, are still eligible to file claims, as the statute of limitations is running out [1]

Group 1 - The ongoing investor compensation case against Silver River Technology (银江技术) is being actively pursued, with multiple filings submitted to the court, and the legal team is accepting additional claims from other investors [1] - Silver River Technology has been found guilty of several violations, including failure to disclose non-operating fund occupation by related parties and significant omissions in financial reports from 2018 to 2023 [1] - Investors who purchased Silver River Technology shares between April 19, 2019, and April 30, 2024, and sold or held the shares after April 30, 2024, may initiate compensation claims based on the violations identified [1] Group 2 - Yangzi New Materials (扬子新材) has received an administrative penalty from the China Securities Regulatory Commission (CSRC) for significant omissions in its annual report, including undisclosed related party fund occupations [2] - The company also faced accusations of false reporting, with approximately 137 million yuan in inflated revenue reported in 2020, which constituted about 11% of the total reported revenue for that year [4] - Investors who bought Yangzi New Materials shares between April 29, 2019, and December 30, 2022, and sold or held the shares after December 30, 2022, are eligible to file compensation claims based on the identified violations [4]

Core Viewpoint - The news highlights ongoing legal actions and claims against Ningke Biological and Caesar Culture, with investors seeking compensation due to alleged misconduct and financial discrepancies by these companies [1][2][3][4]. Group 1: Ningke Biological (600165) - Ningke Biological has received a court ruling in favor of investors, allowing them to claim compensation [1]. - The company is undergoing restructuring, with a court decision to accept its reorganization plan, and the deadline for creditors to file claims has been extended to October 31, 2025 [1]. - The proposed repayment plan for ordinary creditors includes cash repayment for amounts up to 150,000 yuan, while amounts exceeding this will be compensated with trust beneficiary rights and additional shares [1]. Group 2: Caesar Culture (002425) - Caesar Culture has been penalized by the Guangdong Securities Regulatory Bureau for financial misconduct, including failing to disclose significant debts and inflating profits by 15.55% in its 2021 annual report [3][4]. - Investors who purchased Caesar Culture shares between April 27, 2022, and May 6, 2024, may also initiate claims for compensation [4]. - The company is currently facing legal scrutiny, with claims being filed against it for alleged false statements and failure to disclose major events [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 2025年10月22日，上海久诚律师事务所许峰律师代理的朗进科技（维权）（300594）投资者索赔案已获 得济南市中级人民法院立案，目前正在等待法院的下一步安排。律师团队还在继续推进后续案件的立案 工作，还在接受其他投资者的索赔委托。（许峰律师专栏） 2025年8月27日晚，朗进科技公告于2025年8月27日收到证监会分别对公司和实际控制人之一李敬茂先生 下发的《立案告知书》，因公司和实际控制人之一李敬茂先生涉嫌信息披露违法违规，根据《证券法》 《行政处罚法》等法律法规，证监会决定对公司和李敬茂先生立案。 许峰律师认为，暂定在2025年8月28日之前买入朗进科技股票，并在2025年8月28日后卖出或继续持有股 票的投资者，目前还可发起索赔。（朗进科技维权入口） 此前2023年12月29日，苏大维格公告收到江苏证监局下发的《行政处罚决定书》，经查明，当事人存在 以下违法事实： 2023年9月14日12时25分，苏大维格在深交所互动易平台（以下简称互动易）对投资者前期关于"贵司光 刻机及相关技术有哪些知名企业在使用"的提问，回复称"公司光刻机已实现向国内龙头芯片企 ...

除了亿利洁能投资者索赔案再次提交立案，许峰律师提示，思美传媒（维权）（002712）虚假陈述索赔 案已有投资者胜诉先例。 许峰律师代理的亿利洁能投资者索赔案已多次向法院提交立案，目前正在等待法院的下一步安排。律师 团队目前还在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。 2025年9月12日，亿利洁能公告收到证监会内蒙古监管局《行政处罚事先告知书》，经查明，亿利洁 能、亿利集团涉嫌存在以下违法事实： 一、亿利洁能在股票和债券市场披露的信息存在虚假记载、重大遗漏 1、2016年至2022年，亿利洁能及其子公司通过虚增利润、资产、收入等进行财务造假。 2、2017年至2022年，亿利洁能及其子公司为控股股东及其关联方提供担保。 3、2016年至2023年，亿利洁能及其子公司通过与相关银行签订集团资金管理协议、承兑汇票扣款、支 付无商业实质的工程款等形式，直接或间接向控股股东及其关联方提供资金。 二、亿利洁能欺诈发行公司债券。 许峰律师认为，综合以上违法事实，根据证券法规定，在2017年4月18日到2024年4月24日之间买入亿利 洁能股票，并在2024年4月24日之后卖出或持有股票的投资者，目前 ...

Core Insights - Investors in Caesar Travel (000796) may initiate claims due to false statements, with a precedent of successful lawsuits [1] - The company has been penalized by the Hainan Securities Regulatory Bureau for non-operational fund occupation from January 2020 to December 2022 [1] - Gold One Culture (002721) also faces investor claims with a history of successful lawsuits, having reported insufficient inventory impairment leading to inflated profits [1][2] Summary of Key Points Caesar Travel (000796) - The company was found to have engaged in non-operational fund occupation through various means, including fund borrowing and payments to related parties, from January 2020 to December 2022 [1] - As of December 2023, the company has completed rectification of the fund occupation issues [1] - Investors who purchased shares between January 8, 2020, and September 5, 2023, may still file for compensation if they sold or held shares after September 5, 2023 [1] Gold One Culture (002721) - The company was penalized for insufficient inventory impairment in 2020 and 2021, resulting in inflated inventory and profits [1] - In 2020, the company overstated inventory by 610 million, which was 5.92% of total assets, and inflated profit by the same amount, accounting for 21.21% of total profit [1] - In 2021, the company overstated inventory by 637 million, representing 7.03% of total assets, and inflated profit by 28 million, which was 1.89% of total profit [1] - Investors who bought shares between April 30, 2021, and May 1, 2023, can still file claims, with the case nearing its deadline [2]